Days before an Iranian stem cell scientist was due to plead guilty and be sentenced to time served by an Atlanta judge as part of a carefully negotiated prisoner swap that would lead to the release by Iran of Princeton graduate student Xiyue Wang, a potential spoiler emerged.
State Department Iran envoy Brian Hook sent a message to the Swiss and Iranians that former New Mexico governor and US Ambassador to the United Nations Bill Richardson was not authorized to negotiate the swap by the US government, according to a person involved in the negotiations. Instead, the Justice Department directed the USattorney in Atlanta to drop all charges against the stem cell scientist, Masoud Soleimani.
We had a plea agreement that had been agreed to by the US attorney in Atlanta and defense counsel, and was awaiting the judges acceptance on Dec. 11, former Kansas Democratic Rep. James Slattery, who worked pro bono to try to help attorney JasonPoblete secure Wangs release, told Al-Monitor. The court date was set for Dec. 11 for the judge to review the plea agreement. It was certain to be approved by a federal judge. After that, Dr. Soleimani would have been sentenced to time served and released.
And then the Justice Department intervenes with the US attorney, and basically directs the US attorney to drop all charges, Slattery continued. Thats how that all happened.
The swap proceeded in Zurich on Dec. 8, with the charges dropped against Soleimani rather than a plea deal. Hook had flown on a plane with Soleimani, who was in the custody of US marshals until he was turned over to Iranian officials. Wang was flown to Zurich from Tehran on a flight with Iranian Foreign Minister Mohammad Javad Zarif and a senior foreign ministry adviser on Latin American affairs, Mohsen Baharvand.
Hook subsequently said that he and Baharvand did not converse at the swap, calling it a missed opportunity, and suggesting that Baharvand may not have been authorized to speak with a USofficial.
We demonstrated with the prisoner exchange that we know how to work together and reach a deal, Hook toldan audience at the Council on Foreign Relationson Dec. 12.I do hope this exchange is a first step.
Hook did not immediately respond to a query from Al-Monitor on why he had allegedly intervened in the potential swap preparations in the final days, before subsequently jumping in and claiming credit.
Mickey Bergman, the vice president of the Richardson Centerfor Global Engagement which had been approached by the Wang family as well as others held in Iran, Syria, Venezuela, North Korea and Russia to try to secure their release, and had been engaged with both Zarif and officials at the National Security Council and Justice Department for months said the important thing is that Wang was home.
"The Wang-Soleimani exchange proved to the Iranians that we can deliver, not only talk; and it proved to us, including the US government, that the Iranians are good on their promise to Richardson, Bergman told Al-Monitor. This is very important as there are more Americans in Iran that we want to bring home."
"We work on behalf of the families, Bergman said. While governments have a complex set of interests with any foreign government, we have a singular one: Bring the person home. While we understand the 'bigger picture,' that means that we often need to 'cook' an arrangement on our own, and introduce it to the government only when we feel it is set, otherwise we allow spoilers who don't want a deal, to spoil."
I wish they understood this is not a one-time game, Bergman said of government officials jumping in at the last minute to try to seize control of or credit for a sensitive exchange, noting there are other prisoners whose release they are working to secure.
Bergman said he and Richardson were encouraged by a meetingthey held with Zarif on the sidelines of the Doha Forum on Dec. 15 onthe prospect of securing the homecoming of others held by Iran, including Navy veteran Michael White. They are also working on the case of former FBI agent Bob Levinson, who went missing on Irans Kish Island in 2007.
"Following the Wang-Soleimani exchange, Gov.Richardson sat with Foreign Minster Zarif in Doha, closing the loop on the latest exchange and discussing further humanitarian exchanges, Bergman said."We are working on behalf of and at the request of Michael White's family as well as Bob Levinson's family. Naturally, those two cases were discussed in our meeting with FM Zarif. The discussion was productive. There is a lot of heavy lifting to do, but we are hopeful."
Though Hook, Ivanka Trump and Treasury Secretary Steven Mnuchin also attended the Doha Forum, Zarif said there had been no Iranian official encounters with members of the US government delegation there. No meeting or even accidental encounter in Doha, he told Al-Monitor.
If the Trump administration wants to get to talks with Iran, it should adjust its approach, Bergman said.
If the US wanted to facilitate meaningful dialogue with Iran, either in Zurich during the exchange or in Doha after the exchange, he suggested holding off on announcing new sanctions. Instead, make a positive statement, like the president actually did, but back it up in actions, don't follow it up with slapping additional sanctions. That proved to the Iranians that they couldnt trust the president."
Slattery, who was acquainted with Iransambassador to the United Nations, Majid Takht-Ravanchi, who did his university and graduate studies in Kansas, said he hoped the United Statesand Iran could build on the success of Wangs release.
I learned a lot during these negotiations working with Jason Poblete and Gov. Bill Richardson and the Iranian officials, the former Kansas congressmantold Al-Monitor by email. The Iranian officials did exactly what they promised me they would do.
But Slattery said he had concerns about prisoner swaps, and respected the Justice Departments concerns about politicizing, or the appearance of politicizing, the US legal system. He also urged the US government to ease sanctions thatrestrictIrans ability to procure medicines, because banks donot have the assurances they need to facilitate the transaction.
I do not like prisoner swaps because they can politicize our legal system, he said. We must never charge someone with a crime for political reasons nor should we release someone from prison who has been charged with violating US law for political reasons.Criminal cases should be processed based on the law and facts.
I hope the [US] administration will actively pursue the sale of medicines to Iranthat are excluded from US sanctions, Slattery said. "The people of Iran, including children, senior citizens and the critically ill are suffering from the lack of medicines. USsanctions permit the sale of medicines. Preventing the sale of medicines by denying banks the assurances they need to facilitate the medicine sale transactions empowers the Revolutionary Guard in Iran while causinggreat suffering among the people. This does not serve US interests or Israeli interests.
I urge the administration to be as bold with its diplomatic outreach to Iran as it has been to North Korea, Slattery concluded.The rewards will be far greater.
I believe it's in the interest of all to engage in a comprehensive exchange of detainees on both sides, an Iranian diplomat, speaking not for attribution, said Wednesday.
Nizar Zakka, a Lebanese US green card holder released by Iran in June, said that he and Wangs wife,Hua Qu,had met with US national security adviser Robert OBrien in September and sought to persuade him that the United Statesshould respond to Zarifs overtures that he had authority to negotiate a prisoner swap.
We were very clear, why do you not respond to Zarif, Zakka told Al-Monitor. He said they tried to impress on OBrien, who previously served as Trumps special hostage envoy, that it was the first time that Zarif was mentioning names of Iranians held by the United States that could be potentially released in a swap,
Zakka, who said he was in the same cell with Wang in Iran for two years, expressed joy that he was back. We stayed next to each other for two years, Zakka said. He is a great guy. I am so glad that he is back.
- New Stem Cell Approach Through Using Wavelength Laser Might have Discovered Why Humans Lose Hair - Tech Times - October 5th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial - KMVT - October 5th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WIBW - October 5th, 2021
- Diabetic patient receives stem cell therapy - The Hindu - August 18th, 2021
- COVID- 19 Third Dose Approved for Certain Immunocompromised Individuals - the City of Cambridge - August 18th, 2021
- Acute Myeloid Leukemia Treatment: What You Need to Know - Healthline - August 18th, 2021
- 3D Bioprinting Market Size to Reach USD 2,687.8 Million in 2027 | Increasing Use of 3D Bioprinters in Medical Procedures, Training and Testing Along... - August 18th, 2021
- Some Residents Should Consider Third COVID-19 Vaccine Dose - Wyoming Department of Health - August 18th, 2021
- Stem Cell Alopecia Treatment Market Size, Demand, Growth, Trends, Segmentation and Forecasts to 2028 - The Market Writeuo - The Market Writeuo - August 18th, 2021
- Head-To-Head Phase 3 Trial To Evaluate BTK Inhibitors in MCL - Targeted Oncology - August 18th, 2021
- Safety of Stem Cell Therapy for Chronic Knee Pain Confirmed in New Study - SciTechDaily - August 5th, 2021
- Asia-Pacific Cell Therapy Market8 - Opportunities in the Approval of Kymriah and Yescarta - Markets Insider - August 5th, 2021
- Background should not be a barrier to access stem cell transplant treatment and care - PoliticsHome - August 5th, 2021
- Fate Therapeutics Announces Treatment of First Patient in Landmark Phase 1 Clinical Trial of FT819, the First-ever iPSC-derived CAR T-Cell Therapy |... - August 5th, 2021
- Gliomagenesis is orchestrated by the Oct3/4 regulatory network. - Physician's Weekly - August 5th, 2021
- Improving the Treatment Gap in Diffuse Large B-Cell Lymphoma - Targeted Oncology - August 5th, 2021
- Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress - StreetInsider.com - August 5th, 2021
- MUHS, Nashik to conduct fellowship course in regenerative medicine - BSI bureau - August 5th, 2021
- FDA Hands Out Surprising Rejection of Meduxus and Medac's Treosulfan - BioSpace - August 5th, 2021
- Dr. Flowers on Efforts to Improve Frontline Treatment in DLBCL - OncLive - August 5th, 2021
- Future Directions in the Treatment of Polycythemia Vera - OncLive - August 5th, 2021
- FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-small Cell Lung Cancer - Business Wire - August 5th, 2021
- Cellino Appoints Industry Pioneer Robert J. Palay to the Board - Business Wire - August 5th, 2021
- Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF- Superfamily Member for the Treatment of Cancer - Yahoo Finance - August 5th, 2021
- Stemming the tide of stem-cell treatment scams - Houston Chronicle - July 22nd, 2021
- FDA gives speedy review to Bayer's Parkinson's stem cell therapy - - pharmaphorum - July 22nd, 2021
- John Theurer Cancer Center Investigators Participated in ZUMA-7 Study Showing Value of CAR T-Cell Therapy as Second-Line Treatment for Relapsed Large... - July 22nd, 2021
- Creative Medical Technology Holdings Announces MyeloCelz The Company's Second Regenerative Immunotherapy Product - PRNewswire - July 22nd, 2021
- Kadimastem Patent for cell selection of beta cells to Treat and Potentially Cure Diabetes was Granted in Japan - Yahoo Eurosport UK - July 22nd, 2021
- Bluebird, with little fanfare, is first to bring a second gene therapy to market - BioPharma Dive - July 22nd, 2021
- BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease - Yahoo Finance - July 22nd, 2021
- ViaCyte Appoints Dr. Jon Wilensky as Head of Surgery - PRNewswire - July 22nd, 2021
- Emerging Quadruplets, Novel Targets, and Immunotherapy Advances Personalized Medicine in Multiple Myeloma - OncLive - July 22nd, 2021
- Beyond CAR-T: New Frontiers in Living Cell Therapies - UCSF News Services - July 7th, 2021
- Sleeper cells, cells of origin and hematopoietic stem cells - Brain Tumour Research - July 7th, 2021
- Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML - PRNewswire - July 7th, 2021
- Researchers investigate whether stem cell therapy is safe and effective for treatment-resistant bipolar disease - Newswise - April 18th, 2021
- Stem Cell and Regenerative Therapy Market: Cell Therapy Segment to Dominate Global Market - BioSpace - April 18th, 2021
- First in the nation, FDA-approved Phase II mesenchymal stem cell therapy for Parkinson's disease begins - Newswise - April 18th, 2021
- Cellino Biotech developing tech to help scale stem cell therapies - MedCity News - April 18th, 2021
- Stem cell treatment needed to fight the good fight - Victoria Lookout - April 18th, 2021
- Being bionic: the future of regenerative medicine - Toronto Star - April 18th, 2021
- Treating chronic myeloid leukemia (CML): By phase and more - Medical News Today - April 18th, 2021
- Chemical conversion of human epidermal stem cells into intestinal goblet cells for modeling mucus-microbe interaction and therapy - Science Advances - April 18th, 2021
- Andres Isaias Combining Innovation and Excellence - Influencive - April 18th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 18th, 2021
- Antibiotic Use Prior to Allogeneic Stem Cell Transplantation May Be Linked to Graft Vs Host Disease - Hematology Advisor - April 18th, 2021
- Mucopolysaccharidosis (MPS) Treatment Market Is Rising With Post COVID-19 Impact Analysis, Development, CAGR - Global Banking And Finance Review - April 18th, 2021
- The Recovery Room: News beyond the pandemic April 16 - Medical News Today - April 18th, 2021
- The Governments Watchful Eye on Fraud Stemming from Stem Cell Therapy - JD Supra - April 4th, 2021
- Uprooting Cancer: Innovative Hydrogel Rapidly Reverts Cancer Cells Back to Cancer Stem Cells - SciTechDaily - April 4th, 2021
- Multiple sclerosis: Recent research on causes and treatments - Medical News Today - April 4th, 2021
- First CAR T-Cell Therapy for Multiple Myeloma: Abecma - Medscape - April 4th, 2021
- Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director - Benzinga - April 4th, 2021
- Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy - DocWire News - April 4th, 2021
- Orca-T Offers an Alternative to HSCT With Improved Patient Experience - OncLive - April 4th, 2021
- Russell Health Highlighted in the Silicon Review's '50 Leading Companies of the Year 2021' - PRNewswire - April 4th, 2021
- Gracell Biotechnologies Announces Enrollment of First Patient in Registrational Phase 1/2 Clinical Study for GC007g, an Allogeneic CAR-T Cell Therapy... - April 4th, 2021
- LGL Leukemia: Overview, Symptoms, and Treatment - Healthline - April 4th, 2021
- Funding the Next Generation of Cancer Therapies - Genetic Engineering & Biotechnology News - April 4th, 2021
- RenovaCare Announces Organizational Changes and Appointment of New Officers - GlobeNewswire - April 4th, 2021
- Stem Cell Therapy Market expected to reach USD 16.51 Billion by 2025 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - March 8th, 2021
- Creative Medical Technology Holdings Publishes Efficacy in Pain Reduction and Mobility in Patients with Disc Degenerative Disc Using StemSpine... - March 8th, 2021
- New Controversy for Stem Cell Therapy That Repairs Spinal Cords - The Great Courses Daily News - March 8th, 2021
- Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform - Business Wire - March 8th, 2021
- Scar-Forming Cells Switch to Producing New Neurons that Promote Functional Recovery in Mice after Spinal Cord Injury - Genetic Engineering &... - March 8th, 2021
- Moderna Hires Harvard Stem Cell Researcher Jonathan Hoggatt as Director of Hematology: What You Need to Know - Yahoo Finance - March 8th, 2021
- Stem Cell Banking Market Report 2021 | Growth and Opportunities Analysis - BioSpace - February 19th, 2021
- Global Cell Therapy Biomanufacturing Market (2020 to 2025) - Featuring Lonza Group, Merck & Novartis Among Others - ResearchAndMarkets.com -... - February 19th, 2021
- Off-the-Shelf NK Immunotherapy Is Safe and Promising in B-Cell NHL With Chemotherapy and Transplant - Targeted Oncology - February 17th, 2021
- Braunschweig Makes the Case for Earlier Use of CAR T-Cell Therapy in DLBCL - OncLive - February 17th, 2021
- Creative Medical Technology Holdings Files Patent on Prevention of Organ Transplant Rejection using ImmCelz - PRNewswire - February 17th, 2021
- Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021 - Business Wire - February 17th, 2021
- Novartis, Gates Foundation pursue a simpler gene therapy for sickle cell - STAT - February 17th, 2021
- CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results - GlobeNewswire - February 17th, 2021
- Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation... - February 14th, 2021
- Zebrafish reveal regenerative protein that could inspire new treatments for muscle-wasting diseases and aging - FierceBiotech - February 11th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 11th, 2021
- Neurons from patient blood cells enable researchers to test treatments for genetic brain disease - Brown University - February 11th, 2021